CSIMarket Company Name, Ticker, Customers, else..
 
Fortrea Holdings Inc   (NASDAQ: FTRE)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $17.7000 $-0.92 -4.941%
Day's High: $18.389999389648438 Week Perf: -3.65 %
Day's Low: $ 17.65 30 Day Perf: 0.06 %
Volume (M): 762,077 52 Wk High: $ 21.39
Volume (M$): $ 0 52 Wk Avg: $13.70
Open: $18.25 52 Wk Low: $8.31



 Market Capitalization (Millions $) 1,678
 Shares Outstanding (Millions) 95
 Employees 14,300
 Revenues (TTM) (Millions $) 2,677
 Net Income (TTM) (Millions $) -85
 Cash Flow (TTM) (Millions $) 46
 Capital Exp. (TTM) (Millions $) 39

Business Description


Fortrea Holdings Inc is a holding company that operates in various industries such as technology, healthcare, and finance. They invest in and manage a diverse portfolio of companies across these sectors. The company focuses on acquiring and developing businesses with strong growth potential and aims to generate long-term value for its shareholders. Fortrea Holdings Inc is known for its strategic approach to investment and its ability to identify promising opportunities in different markets.


   Company Address: 8 Moore Drive Durham 27713 NC
   Company Phone Number: 495-0816   Stock Exchange / Ticker: NASDAQ FTRE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BGLC   -6.45%    
CFOR   -2.93%    
GH   -0.06%    
GRAL        0.43% 
NTRA        0.59% 
PSNL        0.76% 
• View Complete Report
   



Clinical Study

for This Fortrea Introduces AI Innovation Studio to Uphold Clinical Trial Delivery

Published Thu, Jun 27 2024 11:00 AM UTC

A Bold Leap Forward: Fortrea Establishes AI Innovation Studio to Transform Clinical Trial Delivery DURHAM, N.C., June 27, 2024 In a groundbreaking move, Fortrea (Nasdaq: FTRE), a prominent global contract research organization (CRO), has unveiled its new artificial intelligence (AI) Innovation Studio. This strategic initiative underscores Fortrea s commitment to leveragi...
Product Service News

Fortrea Successfully Divests Endpoint Clinical and Patient Access Businesses, Advancing Growth Strategy in Partnershi...

Published Tue, Jun 4 2024 11:00 AM UTC

Fortrea, a renowned global contract research organization (CRO), has recently concluded the divestiture of its Enabling Services segment assets, encompassing Endpoint Clinical (Endpoint) and Fortrea Patient Access (FPA) businesses, to Arsenal Capital Partners. This strategic move establishes Fortrea s commitment to building market-leading, technology-rich healthcare and indu...
Product Service News

Martin Silver Scholarship for Entrepreneurship: Igniting the Entrepreneurial Spirit in ...

Published Fri, May 31 2024 5:16 PM UTC

Martin Silver Scholarship for Entrepreneurship: A Prestigious Opportunity for Aspiring InnovatorsThe Martin Silver Scholarship for Entrepreneurship has recently announced its 2024-2025 application cycle, offering a unique opportunity for ambitious undergraduate students seeking to pursue their entrepreneurial dreams. With a generous cash prize of $2,500, this esteemed schol...
Product Service News

Advancing Diversity, Inclusion, and Patient Access in Clinical Research through Fortrea...

Published Thu, May 30 2024 11:00 AM UTC

In an era where inclusivity and diversity are at the forefront of social, economic, and scientific progress, it is imperative that the medical field also reflects the diverse patient populations it serves. Fortrea, a pioneering company in clinical research, has unveiled a groundbreaking solution to enhance diversity and inclusion in this domain. Leveraging real-world data, p...
Contract

Fortrea Pioneers Strategic Transformation with Divestiture, Fueling Specialization in Contract Research

Published Mon, Mar 11 2024 10:30 AM UTC

Fortrea Streamlines Strategic Focus with Divestiture of Endpoint Clinical and Patient Access BusinessesFortrea, a leading contract research organization, has announced the signing of a definitive agreement to divest its Endpoint Clinical and Fortrea Patient Access businesses to Arsenal Capital Partners. This move marks a significant step in Fortrea s strategic plan to stream...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.63
Price to Sales (Expected) -
Price to Book 3.2
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.17
Working Capital Ratio 0.96
Leverage Ratio (MRQ) 4.18
Total Debt to Equity 2.01
Interest Coverage (TTM) 1.01
Debt Coverage (TTM) 0.09

Per Share Current
Earnings (TTM) -0.91 $
Revenues (TTM) 28.23 $
Cash Flow (TTM) 0.48 $
Cash 1.78 $
Book Value 5.53 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 187,168
Net Income per Employee (TTM) -5,958
Receivable Turnover Ratio (TTM) 56.65
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.99

Profitability Ratios Current
Gross Margin (MRQ) 20.52 %
Operating Margin (MRQ) 2.18 %
Net Margin (MRQ) -1.95 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Fortrea Holdings Inc's Segments
North America    90.9 % of total Revenue
Europe    63.93 % of total Revenue
Other Geographical Areas    39.02 % of total Revenue
Clinical Services    193.85 % of total Revenue

  Fortrea Holdings Inc Outlook

On March 3 2025 the Fortrea Holdings Inc provided following guidance

nnFortrea Holdings Inc. Reports Fourth Quarter and Annual Results for 2024; Issues Outlook for 2025nn

Fo...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.